• 제목/요약/키워드: Post Translational Modification

검색결과 115건 처리시간 0.026초

Enigma of Small Peptides Ubiquitin and SUMO in Plants

  • Seo, Hak Soo
    • 한국육종학회지
    • /
    • 제42권4호
    • /
    • pp.339-343
    • /
    • 2010
  • Post-translational covalent modifications by small molecules or peptides remodel target proteins. One such modification, made by ubiquitin or small ubiquitin-related modifier (SUMO), is a rapidly expanding field in cell signaling pathways. Ubiquitin attachment controls the turnover and degradation of target proteins while SUMO conjugation regulates their activity and function. Recent studies report many examples of cross-talk between ubiquitin and SUMO pathways, indicating that the boundary is no longer clear. Here, we review recent progress concerning how ubiquitin and SUMO participate in new regulatory roles in plant cell, and how ubiquitination and sumoylation control plant growth and development.

MODf : 대규모 단백질 DB에서 효과적이고 빠르게 PTM을 동정하는 알고리즘 (MODf : An Effective and Fast Algorithm for Identification of PTM in Large Protein Sequence Database)

  • 신성호;박희진;백은옥
    • 한국정보처리학회:학술대회논문집
    • /
    • 한국정보처리학회 2010년도 추계학술발표대회
    • /
    • pp.1834-1836
    • /
    • 2010
  • 프로테오믹스는 세포 안 또는 개체 안의 모든 단백질을 총체적으로 연구하는 분야이다. 단백질 동정은 단백질이 어떤 아미노산의 서열로 구성되었는지를 확인하는 것이다. 하지만 Post-translational modification과 같은 단백질 변형을 고려하게 되면 단백질 동정은 매우 어렵게 된다. $MOD^i$ 알고리즘은 단백질 동정을 할 때 Post-translational modification의 종류나 개수에 제한 없이 단백질 동정을 정확하게 수행한다. 하지만, 대용량 단백질 서열 데이터베이스를 사용하면 수행시간이 많이 걸리는 단점이 있다. 본 논문에서는 $MOD^i$를 보완하기 위해 대용량 데이터베이스에서 후보 단백질을 선정하는 알고리즘을 통해서 개선된 $MOD^f$ 알고리즘을 제안하고 Target-decoy search strategy를 적용하여 정확성을 분석한다. 후보 단백질 선정 알고리즘과 Target-decoy search strategy 적용 결과 $MOD^f$$MOD^i$에 비해 정확도를 희생하지 않으면서 수행속도는 약 2배 향상되었다.

인삼의 polyacetylene 계 성분이 Ras 단백질 변형 효소의 활성에 미치는 영향과 인삼의 석유에텔 추출물이 세포주기에 미치는 영향 (Effects of Polyacetylenes in Ginseng on Activity of Enzymes Related to Post-translational Modification of Ras Protein and Effects of Petroleum Ether Extract of Ginseng on Progression of Cell Cycle)

  • 김동청;이지영;인만진;채희정;황윤경;황우익
    • Journal of Ginseng Research
    • /
    • 제25권4호
    • /
    • pp.156-161
    • /
    • 2001
  • 인삼의 항암효과의 분자적 기전을 규명하기 위하여 인삼의 성분 중 강력한 항암효과를 가지는 것으로 보고된 polyacetylene 계 성분이 Ras 단백질의 post-translational modification에 관여하는 효소인 farnesyl protein trasnferase(FPTase)와 carboxyl methyl transferase(CMTase)의 활성에 미치는 영향을 확인하였고, 인삼의 지용성 성분(PEE)이 세포주기에 미치는 영향을 확인하였다. 소의 뇌로부터 FPTase와 CMTase를 부분정제하여 인삼의 polyacetylene계 성분이 두 효소의 활성에 미치는 영향을 확인한 결과, FPTase는 10mM panaxynol과 10mM panaxydol에 의해서 효소활성이 각각 16.2%와 21.3% 저해받았고, CMTase 효소활성은 polyacetylene계 성분인 panaxynol과 pnanxydol에 의해서 활성을 저해받지 않는 것으로 나타났다. 인체 결장 암세포인 HT-29와 인체 간암세포인 HepG2의 배양액에 인삼의 PEE 성분의 첨가배양시 세포크기가 상당히 위축되며 사멸되었음을 볼 수 있었고, 세포주기 분석 결과 인삼의 PEE 성분의 첨가배양시 G1 단계 세포가 증가하고, S단계세포가 감소하여 세포주기의 진행이 G1-S 단계에서 현저히 억제됨을 나타내었다. 이상의 결과로 보아 인삼의 지용성 성분에 의한 항암효과는 Ras의 post-translational modification 에 관여하는 효소의 활성저해에 기인하기보다는 세포주기의 진행 과정에서 세포주기 조절인자들의 발현변화 및 세포주기의 진행에 관여하는 단백질의 활성억제와 관련이 있을 것으로 사료된다.

  • PDF

Tyrosine phosphorylation as a signaling component for plant improvement

  • Park, Youn-Il;Yang, Hyo-Sik;Oh, Man-Ho
    • Journal of Plant Biotechnology
    • /
    • 제42권4호
    • /
    • pp.277-283
    • /
    • 2015
  • Plant genome analyses, including Arabidopsis thaliana showed a large gene family of plant receptor kinases with various extracellular ligand-binding domain. Now intensively studies to understand physiological and cellular functions for higher plant receptor kinases in diverse and complex biological processes including plant growth, development, ligands perception including steroid hormone and plant-microbe interactions. Brassinosteroids (BRs) as a one of well know steroid hormone are plant growth hormones that control biomass accumulation and also tolerance to many biotic and abiotic stress conditions and hence are of relevance to agriculture. BRI1 receptor kinase, which is localized in plasma membrane in the cell sense BRs and it bind to a receptor protein known as BRASSINOSTEROID INSENSITIVE 1 (BRI1). Recently, we reported that BRI1 and its co-receptor, BRI1-ASSOCIATED KINASE (BAK1) autophosphorylated on tyrosine residue (s) in vitro and in vivo and thus are dual-specificity kinases. Other plant receptor kinases are also phosphorylated on tyrosine residue (s). Post-translational modifications (PTMs) can be studied by altering the residue modified by directed mutagenesis to mimic the modified state or to prevent the modification. These approaches are useful to not only characterize the regulatory role of a given modification, but may also provide opportunities for plant improvement.

In vivo putative O-GlcNAcylation of human SCP1 and evidence for possible role of its N-terminal disordered structure

  • Koo, JaeHyung;Bahk, Young Yil
    • BMB Reports
    • /
    • 제47권10호
    • /
    • pp.593-598
    • /
    • 2014
  • RNA polymerase II carboxyl-terminal domain (RNAPII CTD) phosphatases are responsible for the dephosphorylation of the C-terminal domain of the small subunit of RNAPII in eukaryotes. Recently, we demonstrated the identification of several interacting partners with human small CTD phosphatase1 (hSCP1) and the substrate specificity to delineate an appearance of the dephosphorylation catalyzed by SCP1. In this study, using the established cells for inducibly expressing hSCP1 proteins, we monitored the modification of ${\beta}$-O-linked N-acetylglucosamine (O-GlcNAc). O-GlcNAcylation is one of the most common post-translational modifications (PTMs). To gain insight into the PTM of hSCP1, we used the Western blot, immunoprecipitation, succinylayed wheat germ agglutinin-precipitation, liquid chromatography-mass spectrometry analyses, and site-directed mutagenesis and identified the $Ser^{41}$ residue of hSCP1 as the O-GlcNAc modification site. These results suggest that hSCP1 may be an O-GlcNAcylated protein in vivo, and its N-terminus may function a possible role in the PTM, providing a scaffold for binding the protein(s).

Regulatory Network of ARF in Cancer Development

  • Ko, Aram;Han, Su Yeon;Song, Jaewhan
    • Molecules and Cells
    • /
    • 제41권5호
    • /
    • pp.381-389
    • /
    • 2018
  • ARF is a tumor suppressor protein that has a pivotal role in the prevention of cancer development through regulating cell proliferation, senescence, and apoptosis. As a factor that induces senescence, the role of ARF as a tumor suppressor is closely linked to the p53-MDM2 axis, which is a key process that restrains tumor formation. Thus, many cancer cells either lack a functional ARF or p53, which enables them to evade cell oncogenic stress-mediated cycle arrest, senescence, or apoptosis. In particular, the ARF gene is a frequent target of genetic and epigenetic alterations including promoter hyper-methylation or gene deletion. However, as many cancer cells still express ARF, pathways that negatively modulate transcriptional or post-translational regulation of ARF could be potentially important means for cancer cells to induce cellular proliferation. These recent findings of regulators affecting ARF protein stability along with its low levels in numerous human cancers indicate the significance of an ARF post-translational mechanism in cancers. Novel findings of regulators stimulating or suppressing ARF function would provide new therapeutic targets to manage cancer- and senescence-related diseases. In this review, we present the current knowledge on the regulation and alterations of ARF expression in human cancers, and indicate the importance of regulators of ARF as a prognostic marker and in potential therapeutic strategies.

Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease

  • Yoo, Hajung;Lee, Jeongmin;Kim, Bokwang;Moon, Heechang;Jeong, Huisu;Lee, Kyungmi;Song, Woo Jeung;Hur, Junho K.;Oh, Yohan
    • BMB Reports
    • /
    • 제55권7호
    • /
    • pp.323-335
    • /
    • 2022
  • Together with neuronal loss, the existence of insoluble inclusions of alpha-synuclein (α-syn) in the brain is widely accepted as a hallmark of synucleinopathies including Parkinson's disease (PD), multiple system atrophy, and dementia with Lewy body. Because the α-syn aggregates are deeply involved in the pathogenesis, there have been many attempts to demonstrate the mechanism of the aggregation and its potential causative factors including post-translational modifications (PTMs). Although no concrete conclusions have been made based on the previous study results, growing evidence suggests that modifications such as phosphorylation and ubiquitination can alter α-syn characteristics to have certain effects on the aggregation process in PD; either facilitating or inhibiting fibrillization. In the present work, we reviewed studies showing the significant impacts of PTMs on α-syn aggregation. Furthermore, the PTMs modulating α-syn aggregation-induced cell death have been discussed.

단백질 분해가 식물의 진균 병 진전에 미치는 영향 (The Roles of Protein Degradation During Fungal-plant Interactions)

  • 안일평;박상렬;배신철
    • 한국균학회지
    • /
    • 제38권2호
    • /
    • pp.89-94
    • /
    • 2010
  • 농업경영측면에서, 또 균학적생화학적 측면에서도 식물을 침해하는 진균들의 연구는 반드시 필요하며 병 발생이나 저항성 발현 기작 구명은 기주와 기생체에 대한 연구를 동시에 진행해야 정확히 파악할 수 있다. 현재 병원균이 생산하는 분비체상과 비병원성 인자에 대한 연구는 많은 경우 세균에서 수행되고 있으며 사상균 중 조균인 Phytophthora와 진균인 Cladosporium에서만 병원균의 effector 복합체와 기주의 저항성 기제 간 관계가 같이 진행되고 있을 뿐이다. 앞에서 살펴보았듯 진균-기주 체계에서 단백질 분해가 병원성 조절 및 침입에 관여한다고 정확히 알려진 것은 단지 수종에 불과하며 그 기작도 세포자가포식과 ubiquitin 부가반응에 제한되어 있다. Post translational modification과 단백질 분해기작이 대단히 다양하고 거의 모든 진핵생물 체계에서 관찰되고 있음을 고려할 때 단백질 분해 과정은 세균 뿐 아니라 진균에서도 병원성 발현과 저항성 조절에 참여하고 있을 것으로 생각되며 이에 대한 연구가 앞으로 계속 요구될 것이라 생각된다.

SARS-CoV-2 Infection Induces HMGB1 Secretion Through Post-Translational Modification and PANoptosis

  • Man Sup Kwak;Seoyeon Choi;Jiseon Kim;Hoojung Lee;In Ho Park;Jooyeon Oh;Duong Ngoc Mai;Nam-Hyuk Cho;Ki Taek Nam;Jeon-Soo Shin
    • IMMUNE NETWORK
    • /
    • 제23권3호
    • /
    • pp.25.1-25.17
    • /
    • 2023
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces excessive pro-inflammatory cytokine release and cell death, leading to organ damage and mortality. High-mobility group box 1 (HMGB1) is one of the damage-associated molecular patterns that can be secreted by pro-inflammatory stimuli, including viral infections, and its excessive secretion levels are related to a variety of inflammatory diseases. Here, the aim of the study was to show that SARS-CoV-2 infection induced HMGB1 secretion via active and passive release. Active HMGB1 secretion was mediated by post-translational modifications, such as acetylation, phosphorylation, and oxidation in HEK293E/ACE2-C-GFP and Calu-3 cells during SARS-CoV-2 infection. Passive release of HMGB1 has been linked to various types of cell death; however, we demonstrated for the first time that PANoptosis, which integrates other cell death pathways, including pyroptosis, apoptosis, and necroptosis, is related to passive HMGB1 release during SARS-CoV-2 infection. In addition, cytoplasmic translocation and extracellular secretion or release of HMGB1 were confirmed via immunohistochemistry and immunofluorescence in the lung tissues of humans and angiotensin-converting enzyme 2-overexpressing mice infected with SARS-CoV-2.

Posttranslational and epigenetic regulation of the CLOCK/BMAL1 complex in the mammalian

  • Lee, Yool;Kim, Kyung-Jin
    • Animal cells and systems
    • /
    • 제16권1호
    • /
    • pp.1-10
    • /
    • 2012
  • Most living organisms synchronize their physiological and behavioral activities with the daily changes in the environment using intrinsic time-keeping systems called circadian clocks. In mammals, the key molecular features of the internal clock are transcription- and translational-based negative feedback loops, in which clock-specific transcription factors activate the periodic expression of their own repressors, thereby generating the circadian rhythms. CLOCK and BMAL1, the basic helix-loop-helix (bHLH)/PAS transcription factors, constitute the positive limb of the molecular clock oscillator. Recent investigations have shown that various levels of posttranslational regulation work in concert with CLOCK/BMAL1 in mediating circadian and cellular stimuli to control and reset the circadian rhythmicity. Here we review how the CLOCK and BMAL1 activities are regulated by intracellular distribution, posttranslational modification, and the recruitment of various epigenetic regulators in response to circadian and cellular signaling pathways.